Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a €85.30 Price Target at JPMorgan Chase & Co.

JPMorgan Chase & Co. set a €85.30 ($99.19) price target on Fresenius Medical Care AG & Co. KGaA (ETR:FME) in a research report sent to investors on Wednesday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

A number of other equities analysts also recently weighed in on the stock. Credit Suisse Group set a €71.00 ($82.56) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research note on Thursday, July 18th. Nord/LB set a €92.00 ($106.98) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Friday, May 3rd. Independent Research set a €74.00 ($86.05) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a neutral rating in a research note on Monday, June 17th. Deutsche Bank set a €100.00 ($116.28) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Wednesday, July 24th. Finally, UBS Group set a €92.00 ($106.98) target price on shares of Fresenius Medical Care AG & Co. KGaA and gave the stock a buy rating in a research note on Tuesday, July 30th. Seven equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The stock has an average rating of Buy and a consensus target price of €81.19 ($94.41).

Shares of ETR FME opened at €61.72 ($71.77) on Wednesday. Fresenius Medical Care AG & Co. KGaA has a 1-year low of €55.44 ($64.47) and a 1-year high of €91.74 ($106.67). The company has a market capitalization of $18.84 billion and a P/E ratio of 15.34. The company has a debt-to-equity ratio of 104.77, a quick ratio of 0.13 and a current ratio of 0.99. The business has a 50-day moving average of €68.42.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Story: What does it mean to hold a stock in street name?

Analyst Recommendations for Fresenius Medical Care AG & Co. KGaA (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.